Fennec Pharmaceuticals (FENC) Amortization - Deferred Charges (2019 - 2025)
Fennec Pharmaceuticals posted quarterly Amortization - Deferred Charges of $26000.0 for Q4 2025, up 4.0% year-on-year from $25000.0 in Q4 2024, and up 116.67% on a QoQ basis from $12000.0 in Q3 2025.
Fennec Pharmaceuticals (FENC) has 7 years of Amortization - Deferred Charges data on file, last reported at $26000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortization - Deferred Charges rose 4.0% year-over-year to $26000.0; the trailing twelve-month figure through Dec 2025 stood at $64000.0 (down 28.09% YoY), and the FY2025 full-year result was $64000.0, down 28.09% from the prior year.
- Amortization - Deferred Charges for Q4 2025 stood at $26000.0, up from $12000.0 in the prior quarter.
- Across five years, Amortization - Deferred Charges topped out at $73000.0 in Q2 2023 and bottomed at $7000.0 in Q1 2022.
- The 5-year median for Amortization - Deferred Charges is $22000.0 (2024), against an average of $33611.1.
- The widest annual swing landed in 2021, when Amortization - Deferred Charges tumbled 97.75%; it then soared 928.57% in 2023.
- A 5-year view of Amortization - Deferred Charges shows it stood at $8000.0 in 2021, then surged by 775.0% to $70000.0 in 2022, then changed by 0.0% to $70000.0 in 2023, then plunged by 64.29% to $25000.0 in 2024, then climbed by 4.0% to $26000.0 in 2025.
- The last three Amortization - Deferred Charges figures came in at $26000.0 (Q4 2025), $12000.0 (Q3 2025), and $13000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization - Deferred Charges (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Sep 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 73,000.00 |
| Jun 30, 2023 | 73,000.00 |
| Mar 31, 2023 | 72,000.00 |
| Mar 31, 2023 | 72,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 64,000.00 |
| Sep 30, 2022 | 64,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Sep 30, 2020 | 355,000.00 |
| Sep 30, 2020 | 355,000.00 |
| Jun 30, 2020 | 30,000.00 |
| Jun 30, 2020 | 30,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Jun 30, 2019 | 17,000.00 |
| Jun 30, 2019 | 17,000.00 |
| Mar 31, 2019 | 12,000.00 |
| Mar 31, 2019 | 12,000.00 |